Adaptimmune Therapeutics plc (MUN:473A)
Germany · Delayed Price · Currency is EUR 0.0158
+0.0090 (132.35%)
Last updated: May 14, 2026, 4:32 PM CET
Adaptimmune Therapeutics Employees
Adaptimmune Therapeutics had 506 employees as of December 31, 2024. The number of employees increased by 57 or 12.69% compared to the previous year.
Employees
506
Change (1Y)
57
Growth (1Y)
12.69%
Revenue / Employee
€109,525
Profits / Employee
€285,666
Market Cap
4.53M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 506 | 57 | 12.69% |
| Dec 31, 2023 | 449 | -85 | -15.92% |
| Dec 31, 2022 | 534 | 40 | 8.10% |
| Dec 31, 2021 | 494 | 32 | 6.93% |
| Dec 31, 2020 | 462 | 62 | 15.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Adaptimmune Therapeutics News
- 6 months ago - Adaptimmune Announces Changes to Board and Executive Leadership Team - Newsfile Corp
- 7 months ago - Adaptimmune Announces Delisting from Nasdaq - Newsfile Corp
- 9 months ago - Adaptimmune Reports Q2 Financial Results and Provides Business Update - Newsfile Corp
- 10 months ago - Adaptimmune Announces Entry into Definitive Agreement for Sale of TECELRA, lete-cel, afami-cel and uza-cel Cell Therapies to US WorldMeds - Newsfile Corp
- 1 year ago - Adaptimmune Therapeutics Earnings Call Transcript: Q1 2025 - Transcripts
- 1 year ago - Adaptimmune Reports Q1 Financial Results and Provides Business Update - Newsfile Corp
- 1 year ago - Adaptimmune to Report Q1 2025 Financial and Business Updates on Tuesday, May 13, 2025 - Newsfile Corp
- 1 year ago - Adaptimmune Therapeutics Earnings Call Transcript: Q4 2024 - Transcripts